Financhill
Sell
44

SMMT Quote, Financials, Valuation and Earnings

Last price:
$19.57
Seasonality move :
-4.4%
Day range:
$21.77 - $23.03
52-week range:
$6.78 - $36.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16,804.24x
P/B ratio:
47.62x
Volume:
3.5M
Avg. volume:
4.5M
1-year change:
176.69%
Market cap:
$16.4B
Revenue:
--
EPS (TTM):
-$0.35

Earnings Data

Next earnings date for SMMT
Aug 06
2025
Most recent earnings per share
-$0.09
Beat by $0.00
(May 1/2025)
Consensus Estimate
-$0.09
(May 1/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SMMT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/06/2025 Q2 -- -- -- -$0.09 --
05/01/2025 Q1 -- -- -$0.09 -$0.09 $0.00
02/24/2025 Q4 -- -- -$0.09 -$0.08 -$0.01
10/30/2024 Q3 -- -- -$0.08 -$0.07 -$0.01
08/06/2024 Q2 -- -- -$0.09 -$0.06 -$0.03
05/01/2024 Q1 -- -- -$0.06 -$0.06 -$0.00
02/20/2024 Q4 -- -- -$0.01 -- --
11/07/2023 Q3 -- -- -$0.03 -- --
08/09/2023 Q2 -- -- -$0.02 -- --
05/11/2023 Q1 -- -- -$1.43 -- --
03/09/2023 Q4 -- -- -$0.04 -- --
11/09/2022 Q3 -- -- -$0.14 -- --
08/11/2022 Q2 -- -- -$0.17 -- --
05/11/2022 Q1 -- -- -$0.22 -- --
03/17/2022 Q4 -- -- -$0.28 -- --
11/15/2021 Q3 -- -- -$0.20 -$0.29 $0.09
08/11/2021 Q2 -- -- -$0.27 -$0.18 -$0.09
05/17/2021 Q1 -- -- -$0.21 -$0.17 -$0.04
12/31/2020 Q4 -- -- -$0.18 -$0.21 $0.03
11/16/2020 Q3 -- -- -$0.26 -$0.24 -$0.02
06/30/2020 Q2 -- -- -- -$0.08 --
03/31/2020 Q1 -- -- -$0.01 -$0.02 $0.01
03/27/2020 Q1 -- -- -- -$0.40 --
03/27/2020 Q4 -- -- -- -$0.03 --
12/17/2019 Q4 -- -- -$0.05 -- --
10/11/2019 Q3 -- -- -$0.18 -$0.56 $0.38
06/12/2019 Q2 -- -- -$0.19 -$0.26 $0.06
03/27/2019 Q1 -- -- -$0.33 -- --
12/11/2018 Q4 -- -- -$0.63 -$0.15 -$0.47
09/14/2018 Q3 -- -- $2.43 -$0.39 $2.82
06/05/2018 Q2 -- -- -$0.53 -$0.14 -$0.40
04/11/2018 Q1 -- -- -$1.14 -$0.12 -$1.01
12/06/2017 Q4 -- -- -$0.20 -$0.13 -$0.07
08/31/2017 Q3 -- -- $1.09 $0.32 $0.77
06/14/2017 Q2 -- -- -$0.51 -- --
03/29/2017 Q1 -- -- -$0.50 -- --

Summit Therapeutics Earnings Questions

  • How Much did Summit Therapeutics Generate in Revenue Last Quarter?

    Summit Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Summit Therapeutics Beat Earnings Last Quarter?

    Summit Therapeutics announced earnings per share of -$0.09 which represents a beat of analyst forecast a -$0.09 per share.

  • Is Summit Therapeutics Profitable?

    Summit Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Summit Therapeutics EPS Next Year?

    Summit Therapeutics's earnings are forecast to decrease from -$0.31 per share to -$0.30 per share next year representing a decrease of -29.2%.

  • When is Summit Therapeutics's Earnings Date?

    Summit Therapeutics's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Ken Griffin Buy Sweetgreen Stock?
Why Did Ken Griffin Buy Sweetgreen Stock?

In Q1, Ken Griffin’s Citadel Advisors purchased nearly 1.3 million…

Where Will Planet Labs’ Stock Go Next?
Where Will Planet Labs’ Stock Go Next?

On 4 June 2025 Planet reported Q1 FY 2026 revenue of $66.3 million, up 10% year over…

Where Will VICI Properties Be in 5 Years?
Where Will VICI Properties Be in 5 Years?

VICI Properties (NYSE:VICI) is a real estate investment trust focused…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
75
INSM alert for Jun 11

Insmed [INSM] is up 7.75% over the past day.

Sell
25
AAON alert for Jun 11

AAON [AAON] is down 3.49% over the past day.

Buy
58
EXOD alert for Jun 11

Exodus Movement [EXOD] is down 8.21% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock